Babcock & Wilcox Enterprises Inc buy krebskrebs
Start price
28.04.20
/
50%
€0.86
Target price
04.11.21
€0.90
Performance (%)
666.08%
End price
05.11.21
€6.55
Summary
This prediction ended on 05.11.21 with a price of €6.55. With a performance of 666.08% the BUY prediction by krebskrebs was a big success. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Babcock & Wilcox Enterprises Inc | 6.369% | 6.369% | 613.675% | 41.525% |
| iShares Core DAX® | -1.432% | 0.000% | 12.331% | 59.631% |
| iShares Nasdaq 100 | -0.386% | -0.595% | 4.688% | 98.396% |
| iShares Nikkei 225® | 1.448% | 5.269% | 18.051% | 50.544% |
| iShares S&P 500 | 0.114% | -0.217% | 1.388% | 63.586% |
Comments by krebskrebs for this prediction
In the thread Babcock & Wilcox Enterprises Inc diskutieren
In the thread Trading Babcock & Wilcox Enterprises Inc
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten